BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cao BL, Qasem A, Sharp RC, Abdelli LS, Naser SA. Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα). World J Gastroenterol 2018; 24(25): 2764-2775 [PMID: 29991880 DOI: 10.3748/wjg.v24.i25.2764]
URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2764.htm
Number Citing Articles
1
Brett D. M. Jones, Zafiris J. Daskalakis, Andre F. Carvalho, Rebecca Strawbridge, Allan H. Young, Benoit H. Mulsant, M. Ishrat Husain. Inflammation as a treatment target in mood disorders: reviewBJPsych Open 2020; 6(4) doi: 10.1192/bjo.2020.43
2
Ahmad Qasem, Erij Elkamel, Saleh A. Naser. Anti-MAP Triple Therapy Supports Immunomodulatory Therapeutic Response in Crohn’s Disease through Downregulation of NF-κB Activation in the Absence of MAP DetectionBiomedicines 2020; 8(11): 513 doi: 10.3390/biomedicines8110513
3
Lifan Zhang, Shijun Wan, Ziyue Zhou, Yueqiu Zhang, Xiaoqing Liu. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot studyBMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06351-w
4
Qin Yu Yang, Yi Juan Liu, Ye Xu, Lin Zhang, Cheng Dang Wang. Monitoring frequency of interferon gamma release assay for tuberculosis surveillance following infliximab therapy in patients with Crohn's diseaseJournal of Digestive Diseases 2021; 22(8): 473 doi: 10.1111/1751-2980.13032
5
Nazan Dalgic, Ayse Sahin, Selda Hancerli Torun, Ozge Kaba, Pinar Onal, Ayse Tekin Yilmaz, Ozden Turel, Belma Yasar, Manolya Kara, Deniz Aygun, Ayse Kilinc, Selim Oncel, Burcu Bursal Duramaz, Nafiye Urganci, Ayper Somer, Haluk Cokugras, Emin Sami Arisoy. Active and Latent Tuberculosis in Children Treated with Anti-TNF-α: A Retrospective Multicenter StudyJournal of Pediatric Infectious Diseases 2022; 17(02): 090 doi: 10.1055/s-0042-1743195
6
Non-Neoplastic Disorders of the Gastrointestinal Tract2021; : 333 doi: 10.55418/9781933477930-05
7
María Florencia Mercogliano, Sofía Bruni, Florencia Mauro, Patricia Virginia Elizalde, Roxana Schillaci. Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer ImmunotherapyCancers 2021; 13(3): 564 doi: 10.3390/cancers13030564
8
Laura Sanchis-Artero, Juan Francisco Martínez-Blanch, Sergio Manresa-Vera, Ernesto Cortés-Castell, Marina Valls-Gandia, Marisa Iborra, Jose Maria Paredes-Arquiola, Maia Boscá-Watts, Jose Maria Huguet, Rafael Gil-Borrás, Josefa Rodríguez-Morales, Xavier Cortés-Rizo. Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatmentScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88823-2
9
Ya He, Ziying Gong, Xiaokai Zhao, Daoyun Zhang, Zhongshun Zhang. Comprehensive Determination of Mycobacterium tuberculosis and Nontuberculous Mycobacteria From Targeted Capture SequencingFrontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00449
10
Jamie L. Waldron, Stephen A. Schworer, Mildred Kwan. Hypersensitivity and Immune-related Adverse Events in Biologic TherapyClinical Reviews in Allergy & Immunology 2021; 62(3): 413 doi: 10.1007/s12016-021-08879-w
11
Esra’a Keewan, Shazia Beg, Saleh A. Naser. Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 SignalingFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.641295
12
Taylor J. Louis, Ahmad Qasem, Saleh A. Naser. Attenuation of Excess TNF-α Release in Crohn’s Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE TraffickingFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.887830
13
Joel V. Chua, John W. Baddley. Infectious Complications in Biologic and Targeted Therapies2022; : 69 doi: 10.1007/978-3-031-11363-5_5
14
Dania AlQasrawi, Ahmad Qasem, Saleh A. Naser. Divergent Effect of Cigarette Smoke on Innate Immunity in Inflammatory Bowel Disease: A Nicotine-Infection InteractionInternational Journal of Molecular Sciences 2020; 21(16): 5801 doi: 10.3390/ijms21165801
15
Xiuqin Mao, Aifang Zhou, Junqin Peng. Role of Neuron-Specific Enolase, D-Dimer and C-Reactive Protein in the Cranial Nerve Injury After Surgery of Posterior Fossa TumorJournal of Biomaterials and Tissue Engineering 2023; 13(12): 1116 doi: 10.1166/jbt.2023.3348
16
Şeyma BAŞLILAR, Mehtap AYDIN. Evaluation of long-term effect of tuberculosis chemoprophylaxis in patients using anti tumor necrosis factor alpha agentsAnatolian Current Medical Journal 2021; 3(2): 115 doi: 10.38053/acmj.854759
17
Dania AlQasrawi, Saleh A. Naser. Nicotine Modulates MyD88-Dependent Signaling Pathway in Macrophages during Mycobacterial InfectionMicroorganisms 2020; 8(11): 1804 doi: 10.3390/microorganisms8111804
18
Giuseppe Murdaca, Simone Negrini, Marco Pellecchio, Monica Greco, Chiara Schiavi, Francesca Giusti, Francesco Puppo. Update upon the infection risk in patients receiving TNF alpha inhibitorsExpert Opinion on Drug Safety 2019; 18(3): 219 doi: 10.1080/14740338.2019.1577817
19
Amna Naser, Ahmad K. Odeh, Robert C. Sharp, Ahmad Qasem, Shazia Beg, Saleh A. Naser. Polymorphisms in TNF Receptor Superfamily 1B (TNFRSF1B:rs3397) are Linked to Mycobacterium avium paratuberculosis Infection and Osteoporosis in Rheumatoid ArthritisMicroorganisms 2019; 7(12): 646 doi: 10.3390/microorganisms7120646
20
Coad Thomas Dow, Leonardo A Sechi. Cows Get Crohn’s Disease and They’re Giving Us DiabetesMicroorganisms 2019; 7(10): 466 doi: 10.3390/microorganisms7100466
21
Ahmad Qasem, Seela Ramesh, Saleh A Naser. Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn’s diseaseBMJ Open Gastroenterology 2019; 6(1): e000246 doi: 10.1136/bmjgast-2018-000246